APA

Overman M. J., Feng L., Pro B., McLaughlin P., Hess M., Samaniego F., Younes A., Romaguera J. E., Hagemeister F. B., Kwak L., Cabanillas F., Rodriguez M. A. & Fayad L. E. (20080312). The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Overman M J, Feng L, Pro B, McLaughlin P, Hess M, Samaniego F, Younes A, Romaguera J E, Hagemeister F B, Kwak L, Cabanillas F, Rodriguez M A and Fayad L E. 20080312. The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Overman M. J., Feng L., Pro B., McLaughlin P., Hess M., Samaniego F., Younes A., Romaguera J. E., Hagemeister F. B., Kwak L., Cabanillas F., Rodriguez M. A. and Fayad L. E. (20080312). The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Overman M J, Feng L, Pro B, McLaughlin P, Hess M, Samaniego F, Younes A, Romaguera J E, Hagemeister F B, Kwak L, Cabanillas F, Rodriguez M A and Fayad L E. The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. : Annals of oncology : official journal of the European Society for Medical Oncology. 20080312.